TCL Archive IOM Omics Committee Offers Blueprint to Prevent Other Duke-Style Disasters March 23, 2012
TCL Archive In Brief: Chabner Says He ”Has No Intention Of Leaving NCI; “Yarbro Named Clinical Indicators Chairman September 2, 1988
TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005
TCL Archive Take Program Direction Away From CCIRC, Form New Group for Clinical Trials, Conferees Suggest June 6, 1975
